middle.news
CSL Reports 5% NPATA Growth, Reaffirms Strong FY25 Outlook
9:06am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
CSL Reports 5% NPATA Growth, Reaffirms Strong FY25 Outlook
9:06am on Monday 2nd of June, 2025 AEST
Key Points
Half-year NPATA of US$2.07 billion, up 5% at constant currency
Revenue increased 5% to US$8.48 billion, led by CSL Behring and CSL Vifor
CSL Seqirus impacted by low influenza immunisation rates, especially in the US
Interim dividend up 16% to approximately A$2.08 per share
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
CSL (ASX:CSL)
OPEN ARTICLE